GIM
FATE icon

Granahan Investment Management’s Fate Therapeutics FATE Stock Holding History

Granahan Investment Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-602,153
Closed -$6.08M – 170
2022
Q4 		$6.08M Buy
602,153
+275,734
+84% +$5.18M 0.19% 119
2022
Q3 		$7.32M Buy
326,419
+63,263
+24% +$1.83M 0.24% 106
2022
Q2 		$6.52M Buy
263,156
+58,211
+28% +$1.61M 0.22% 102
2022
Q1 		$7.95M Buy
204,945
+71,544
+54% +$2.77M 0.2% 106
2021
Q4 		$7.8M Buy
133,401
+58,909
+79% +$3.34M 0.16% 129
2021
Q3 		$4.42M Buy
+74,492
New +$5.84M 0.08% 159

Other funds holding FATE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return